These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Outcome with calcium channel antagonists after myocardial infarction: a community-based study. Leitch JW, McElduff P, Dobson A, Heller R. J Am Coll Cardiol; 1998 Jan; 31(1):111-7. PubMed ID: 9426027 [Abstract] [Full Text] [Related]
3. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry). Amann U, Kirchberger I, Heier M, Zirngibl A, von Scheidt W, Kuch B, Peters A, Meisinger C. Am J Cardiol; 2014 Aug 01; 114(3):329-35. PubMed ID: 24927969 [Abstract] [Full Text] [Related]
6. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction. Kizer JR, Cannon CP, McCabe CH, Mueller HS, Schweiger MJ, Davis VG, Perritt R, Antman EM. Am Heart J; 1999 Jan 01; 137(1):79-92. PubMed ID: 9878939 [Abstract] [Full Text] [Related]
7. Prior calcium channel blockade and short-term survival following acute myocardial infarction. Parsons RW, Hung J, Hanemaaijer I, Jbroadhurst R, Jamrozik K, Hobbs MS. Cardiovasc Drugs Ther; 2001 Nov 01; 15(6):487-92. PubMed ID: 11916357 [Abstract] [Full Text] [Related]
8. Anti-ischaemic therapy during the follow-up phase of acute coronary syndromes. Is there a role for calcium channel blockers? Boden WE. Drugs; 1996 Nov 01; 52 Suppl 4():20-30. PubMed ID: 8913715 [Abstract] [Full Text] [Related]
9. Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011. Gitsels LA, Kulinskaya E, Steel N. BMJ Open; 2017 Jan 24; 7(1):e013570. PubMed ID: 28119386 [Abstract] [Full Text] [Related]
10. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Barron HV, Michaels AD, Maynard C, Every NR. J Am Coll Cardiol; 1998 Aug 24; 32(2):360-7. PubMed ID: 9708461 [Abstract] [Full Text] [Related]
11. Impact of pharmacological treatment on mortality after myocardial infarction in diabetic patients. Zuanetti G, Latini R. J Diabetes Complications; 1997 Aug 24; 11(2):131-6. PubMed ID: 9101399 [Abstract] [Full Text] [Related]
12. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction. Gillman MW, Ross-Degnan D, McLaughlin TJ, Gao X, Spiegelman D, Hertzmark E, Goldman L, Soumerai SB. J Am Geriatr Soc; 1999 May 24; 47(5):512-7. PubMed ID: 10323641 [Abstract] [Full Text] [Related]
13. Treatment of patients with myocardial infarction who present with a paced rhythm. Rathore SS, Weinfurt KP, Gersh BJ, Oetgen WJ, Schulman KA, Solomon AJ. Ann Intern Med; 2001 Apr 17; 134(8):644-51. PubMed ID: 11304104 [Abstract] [Full Text] [Related]
14. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA. JAMA; 1998 Aug 19; 280(7):623-9. PubMed ID: 9718054 [Abstract] [Full Text] [Related]
15. Effects of beta-blockers and calcium channel blockers in acute myocardial infarction. Held PH, Yusuf S. Eur Heart J; 1993 Oct 19; 14 Suppl F():18-25. PubMed ID: 7903243 [Abstract] [Full Text] [Related]
17. [The treatment of ischemia in acute myocardial infarction]. Kiowski W. Schweiz Med Wochenschr; 1990 Oct 20; 120(42):1531-8. PubMed ID: 1978408 [Abstract] [Full Text] [Related]
18. Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (diltiazem) (INTERCEPT) Research Group. Boden WE, Scheldewaert R, Walters EG, Whitehead A, Coltart DJ, Santoni JP, Belgrave G, Starkey IR. Am J Cardiol; 1995 Jun 01; 75(16):1120-3. PubMed ID: 7762497 [Abstract] [Full Text] [Related]
19. Temporal trends in medical therapies for ST- and non-ST elevation myocardial infarction: (from the Atherosclerosis Risk in Communities [ARIC] Surveillance Study). O'Brien EC, Rose KM, Suchindran CM, Sturmer T, Chang PP, Alonso A, Baggett CD, Rosamond WD. Am J Cardiol; 2013 Feb 01; 111(3):305-11. PubMed ID: 23168284 [Abstract] [Full Text] [Related]